Linoleoyl ethanolamide reduces lipopolysaccharide-induced inflammation in macrophages and ameliorates 2,4-dinitrofluorobenzene-induced contact dermatitis in mice

Eur J Pharmacol. 2013 Jan 15;699(1-3):6-13. doi: 10.1016/j.ejphar.2012.11.030. Epub 2012 Nov 28.

Abstract

In our previous study, it was found that linoleoyl ethanolamide (LE) is present in sake lees, which are produced as a byproduct during the making of Japanese sake. LE is a fatty acid ethanolamide, which have been demonstrated to exert a variety of biological functions, and in this study, the anti-inflammatory effects of LE were examined using in vitro cell culture and in vivo animal experiments. In mouse RAW264.7 macrophages, LE suppressed the lipopolysaccharide (LPS)-induced expression of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6. In addition, LE inhibited LPS-induced increases in the levels of cyclooxygenase enzyme-2 and prostaglandin E(2), which are indicators of inflammation. The inhibitory effect of LE on the release of TNF-α was stronger than that of dipotassium glycyrrhizinate, which is widely used in external human skin care treatments. LE also suppressed the LPS-induced activation of Toll-like receptor 4 signaling and nuclear translocation of nuclear factor-κB (NF-κB) p65. In a contact dermatitis animal model, applying LE to affected ear skin ameliorated 2,4-dinitrofluorobenzene-induced contact dermatitis and pro-inflammatory cytokine expression at inflamed sites. These results indicate that LE exerts anti-inflammatory effects by inhibiting NF-κB signaling, and LE is proposed to be a useful therapeutic agent against contact dermatitis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Cell Line
  • Cytokines / metabolism
  • Dermatitis, Contact / drug therapy*
  • Dermatitis, Contact / pathology
  • Dinitrofluorobenzene / toxicity
  • Disease Models, Animal
  • Female
  • Glycyrrhizic Acid / pharmacology
  • Inflammation / drug therapy*
  • Inflammation / pathology
  • Inflammation Mediators / metabolism
  • Linoleic Acids / pharmacology*
  • Lipopolysaccharides / toxicity
  • Macrophages / drug effects
  • Macrophages / pathology
  • Mice
  • Mice, Inbred BALB C
  • NF-kappa B / metabolism
  • Polyunsaturated Alkamides / pharmacology*
  • Signal Transduction / drug effects

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Inflammation Mediators
  • Linoleic Acids
  • Lipopolysaccharides
  • NF-kappa B
  • Polyunsaturated Alkamides
  • linoleoyl ethanolamide
  • Glycyrrhizic Acid
  • Dinitrofluorobenzene